Literature DB >> 16002921

NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases.

Won-Jung Koh1, O Jung Kwon, Eun Joo Kim, Kyung Soo Lee, Chang-Seok Ki, Jong Won Kim.   

Abstract

STUDY
OBJECTIVES: Pulmonary disease caused by nontuberculous mycobacteria (NTM) may occur in patients with no underlying lung disease and no known immunodeficiency. The purpose of this study was to evaluate a potential role for natural-resistance-associated macrophage protein 1 (NRAMP1) gene polymorphisms for human susceptibility to the NTM lung disease.
DESIGN: A case-control study.
SETTING: Tertiary university medical center. PARTICIPANTS: Forty-one adult patients with NTM lung disease (Mycobacterium avium complex infection, 18 patients; Mycobacterium abscessus infection, 23 patients) were included in the study population. The diagnosis of NTM lung disease was made when the patients fulfilled the diagnostic criteria published by the American Thoracic Society. All patients had findings on high-resolution CT scans, such as bilateral bronchiectasis combined with multiple small nodules and branching linear structures, that were characteristic of the nodular bronchiectatic form of NTM lung disease. Fifty healthy individuals were selected as control subjects.
RESULTS: Heterozygotes at intron 4 (469 + 14G/C) [INT4], codon 543 in exon 15 (D543N), and 3' untranslated region (3'UTR) were observed at significantly higher frequencies in patients with NTM lung disease than in control subjects. The odds ratios (ORs) were 2.78 (95% confidence interval [CI], 1.12 to 6.89; p = 0.026) for INT4 G/C, 5.74 (95% CI, 1.48 to 22.30; p = 0.006) for D543 G/A, and 9.54 (95% CI, 2.49 to 36.53; p < 0.001) for 3'UTR TGTG+/del. Subjects who were heterozygous for two NRAMP1 polymorphisms in INT4 and D543N were particularly overrepresented among those with NTM lung disease, compared with those with the most common NRAMP1 genotype (OR, 10.88, 95% CI, 1.18 to 100.45; p = 0.035). There were no significant differences in the frequencies of INT4, D543N, and 3'UTR polymorphisms between the patients with M avium complex infection and those with M abscessus infection.
CONCLUSIONS: These findings suggest that the NRAMP1 genetic polymorphisms are associated with human susceptibility to NTM lung disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002921     DOI: 10.1378/chest.128.1.94

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  21 in total

1.  Whole-Exome Sequencing Identifies the 6q12-q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Fei Chen; Eva P Szymanski; Kenneth N Olivier; Xinyue Liu; Hervé Tettelin; Steven M Holland; Priya Duggal
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

Review 2.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

Review 3.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

4.  Alcohol Consumption Modulates Host Defense in Rhesus Macaques by Altering Gene Expression in Circulating Leukocytes.

Authors:  Tasha Barr; Thomas Girke; Suhas Sureshchandra; Christina Nguyen; Kathleen Grant; Ilhem Messaoudi
Journal:  J Immunol       Date:  2015-11-30       Impact factor: 5.422

Review 5.  Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.

Authors:  Kevin L Winthrop; Michael Iseman
Journal:  Nat Rev Rheumatol       Date:  2013-06-25       Impact factor: 20.543

6.  Diminished Susceptibility of African-Americans to Non-tuberculous Mycobacterial Disease.

Authors:  Jerome M Reich; Jong S Kim
Journal:  Lung       Date:  2017-11-13       Impact factor: 2.584

7.  Personalized medicine approach in mycobacterial disease.

Authors:  Mehdi Mirsaeidi
Journal:  Int J Mycobacteriol       Date:  2012-06

8.  HLA antigens and nontuberculous mycobacterial lung disease in Korean patients.

Authors:  Sang-Won Um; Chang-Seok Ki; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2009-02-14       Impact factor: 2.584

Review 9.  Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.

Authors:  Won-Jung Koh; O Jung Kwon; Kyung Soo Lee
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

10.  Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.

Authors:  Megan E Billinger; Kenneth N Olivier; Cecile Viboud; Ruben Montes de Oca; Claudia Steiner; Steven M Holland; D Rebecca Prevots
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.